Evidence map›Paper›PMID 33473103›Full record

ArticleCell death & disease2021

p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration.

Matthew J Geden, Selena E Romero, Mohanish Deshmukh

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Mitochondrial DNA damage as driver of cellular outcomes.American journal of physiology. Cell physiology · 2022
    Review
  6. Genes and Longevity of Lifespan.International journal of molecular sciences · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matthew J GedenDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, 27599, USA.ORCID 0000-0002-4481-3199
Selena E RomeroDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, 27599, USA.ORCID 0000-0002-1268-4142
Mohanish DeshmukhDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, 27599, USA. mohanish@med.unc.edu.ORCID 0000-0002-2597-5862
University of North Carolina at Chapel Hill · US

Funding

Establishing Apoptotic Thresholds: Insights from Neurons and Stem Cells to CancerR35GM118331 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESHMUKH, MOHANISH P · 2016 to 2020
$2.2M
Mitochondrial DNA damage-induced degeneration: a microfluidic neuronal modelR21NS105506 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESHMUKH, MOHANISH P · 2017 to 2018
$415k
Axon degeneration triggered by chemotherapy-induced mitochondrial DNA damageF31CA186654 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GEDEN, MATTHEW JOHN · 2014 to 2016
$89k
NCI NIH HHS F31 CA186654NIGMS NIH HHS R35 GM118331NINDS NIH HHS R21 NS105506
6 · The paper itself

Abstract

While the consequences of nuclear DNA damage have been well studied, the exact consequences of acute and selective mitochondrial DNA (mtDNA) damage are less understood. DNA damaging chemotherapeutic drugs are known to activate p53-dependent apoptosis in response to sustained nuclear DNA damage. While it is recognized that whole-cell exposure to these drugs also damages mtDNA, the specific contribution of mtDNA damage to cellular degeneration is less clear. To examine this, we induced selective mtDNA damage in neuronal axons using microfluidic chambers that allow for the spatial and fluidic isolation of neuronal cell bodies (containing nucleus and mitochondria) from the axons (containing mitochondria). Exposure of the DNA damaging drug cisplatin selectively to only the axons induced mtDNA damage in axonal mitochondria, without nuclear damage. We found that this resulted in the selective degeneration of only the targeted axons that were exposed to DNA damage, where ROS was induced but mitochondria were not permeabilized. mtDNA damage-induced axon degeneration was not mediated by any of the three known axon degeneration pathways: apoptosis, axon pruning, and Wallerian degeneration, as Bax-deficiency, or Casp3-deficiency, or Sarm1-deficiency failed to protect the degenerating axons. Strikingly, p53, which is essential for degeneration after nuclear DNA damage, was also not required for degeneration induced with mtDNA damage. This was most evident when the p53-deficient neurons were globally exposed to cisplatin. While the cell bodies of p53-deficient neurons were protected from degeneration in this context, the axons farthest from the cell bodies still underwent degeneration. These results highlight how whole cell exposure to DNA damage activates two pathways of degeneration; a faster, p53-dependent apoptotic degeneration that is triggered in the cell bodies with nuclear DNA damage, and a slower, p53-independent degeneration that is induced with mtDNA damage.

Indexed as

DNA DamageCell NucleusDNA, MitochondrialHumansNeuronsTumor Suppressor Protein p53Wallerian DegenerationDNA, MitochondrialTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID33473103
PMCPMC7817838
OpenAlexW3123109080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.